Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ying-Ming Chiu & Der-Yuan Chen. (2020) Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Review of Clinical Immunology 16:2, pages 207-228.
Read now
Read now
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti & Francesco Puppo. (2019) Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 18:3, pages 219-229.
Read now
Read now
Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2016) Prevention of HBV reactivation in patients treated with biologic agents. Expert Review of Clinical Pharmacology 9:4, pages 579-589.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo. (2015) Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 14:4, pages 571-582.
Read now
Read now
Ryu Watanabe, Tomonori Ishii, Kyohei Nakamura, Tsuyoshi Shirai, Yumi Tajima, Hiroshi Fujii & Hideo Harigae. (2013) Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy. Modern Rheumatology 23:6, pages 1094-1100.
Read now
Read now
Articles from other publishers (45)
Alejandro Balsa, Petra Díaz del Campo Fontecha, Lucía Silva Fernández, José Valencia Martín, Virginia Nistal Martínez, Fernando León Vázquez, M. Vanesa Hernández Hernández, Héctor Corominas, Rafael Cáliz Cáliz, José María Aguado García, Gloria Candelas Rodríguez, Nora Ibargoyen Roteta, Arturo Martí Carvajal, M. Nieves Plana Farras, Janet Puñal Riobóo, Hye Sang Park, Yolanda Triñanes Pego & Virginia Villaverde García. (2023) Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatología Clínica (English Edition) 19:10, pages 533-548.
Crossref
Crossref
Alejandro Balsa, Petra Díaz del Campo Fontecha, Lucía Silva Fernández, José Valencia Martín, Virginia Nistal Martínez, Fernando León Vázquez, M. Vanesa Hernández Hernández, Héctor Corominas, Rafael Cáliz Cáliz, José María Aguado García, Gloria Candelas Rodríguez, Nora Ibargoyen Roteta, Arturo Martí Carvajal, M. Nieves Plana Farras, Janet Puñal Riobóo, Hye Sang Park, Yolanda Triñanes Pego & Virginia Villaverde García. (2023) Recomendaciones SER sobre la gestión de riesgo del tratamiento con FAME biológicos o sintéticos dirigidos en pacientes con artritis reumatoide. Reumatología Clínica 19:10, pages 533-548.
Crossref
Crossref
Stamatia Katelani, George E Fragoulis, Athanasios-Dimitrios Bakasis, Abraham Pouliakis, Elena Nikiphorou, Fabiola Atzeni & Theodoros Androutsakos. (2023) HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis. Rheumatology 62:SI3, pages SI252-SI259.
Crossref
Crossref
Xuezhi Hong, Yanhua Xiao, Liyan Xu, Lei Liu, Hailu Mo & Hanyou Mo. (2023) Risk of hepatitis B reactivation in HBsAg−/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta‐analysis. Immunity, Inflammation and Disease 11:2.
Crossref
Crossref
George V. Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, Pietro Lampertico, Thomas Berg, Henry L.Y. Chan, Jia-Horng Kao, Norah Terrault, Anna S. Lok & K. Rajender Reddy. (2022) Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion. Journal of Hepatology 77:6, pages 1670-1689.
Crossref
Crossref
Qiao Zhou, Qi Zhang, Kaiwen Wang, Ting Huang, Shaoping Deng, Yi Wang & Chunming Cheng. (2022) Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma. Pharmacological Research 178, pages 106181.
Crossref
Crossref
Meng Hsuan Kuo, Chih-Wei Tseng, Ming-Chi Lu, Chien-Hsueh Tung, Kuo-Chih Tseng, Kuang-Yung Huang, Chi-Hui Lee & Ning-Sheng Lai. (2021) Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment. Digestive Diseases and Sciences 66:11, pages 4026-4034.
Crossref
Crossref
Takako Inoue, Takeshi Matsui & Yasuhito Tanaka. (2021) Novel strategies for the early diagnosis of hepatitis B virus reactivation. Hepatology Research 51:10, pages 1033-1043.
Crossref
Crossref
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong-Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin & Masao Omata. (2021) APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hepatology International 15:5, pages 1031-1048.
Crossref
Crossref
Hsien-Chung Yu, Jui-Cheng Tseng, Ling-Ying Lu, Jwi-Chieh Hu, Yan-Hua Chen, Chiao-Lin Hsu, Pin-Chieh Wu, Guang-Yuan Mar & Kung-Hung Lin. (2020) Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy. European Journal of Gastroenterology & Hepatology 33:1, pages 107-113.
Crossref
Crossref
Demet YALÇIN KEHRİBAR, Muhammed OKUYUCU, Metin ÖZGEN, Yusuf Bünyamin KETENCİ, Talat AYYILDIZ & Beytullah YILDIRIM. (2020) Impact of tumor necrosis factor alpha antagonist treatment on antibody titer of hepatitis B surface antigen. Journal of Surgery and Medicine 4:8, pages 678-681.
Crossref
Crossref
Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, Takashi Watanabe, Masanobu Nakata, Rika Sakai, Noriyasu Fukushima, Takuya Fukushima, Yukiyoshi Moriuchi, Kuniaki Itoh, Kisato Nosaka, Ilseung Choi, Masashi Sawa, Rumiko Okamoto, Hideki Tsujimura, Toshiki Uchida, Sachiko Suzuki, Masataka Okamoto, Tsutomu Takahashi, Isamu Sugiura, Yasushi Onishi, Mika Kohri, Shinichiro Yoshida, Minoru Kojima, Hiroyuki Takahashi, Akihiro Tomita, Yoshiko Atsuta, Dai Maruyama, Eiji Tanaka, Takayo Suzuki, Tomohiro Kinoshita, Michinori Ogura, Ryuzo Ueda & Masashi Mizokami. (2020) Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma. Journal of Hepatology 73:2, pages 285-293.
Crossref
Crossref
Inkin Ujiie, Hideyuki Ujiie, Norihiro Yoshimoto, Hiroaki Iwata & Hiroshi Shimizu. (2020) Prevalence of infectious diseases in patients with autoimmune blistering diseases. The Journal of Dermatology 47:4, pages 378-384.
Crossref
Crossref
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao & Mark C Genovese. (2020) Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. RMD Open 6:1, pages e001095.
Crossref
Crossref
Florian MORETTO, François-Xavier CATHERINE, Clémentine ESTEVE, Mathieu BLOT & Lionel PIROTH. (2020) Isolated Anti-HBc: Significance and Management. Journal of Clinical Medicine 9:1, pages 202.
Crossref
Crossref
Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2020) Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2091264.
Crossref
Crossref
Stefano Piaserico, Francesco Messina & Francesco Paolo Russo. (2019) Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. American Journal of Clinical Dermatology 20:6, pages 829-845.
Crossref
Crossref
Victoria Furer, Christien Rondaan, Marloes Heijstek, Sander van Assen, Marc Bijl, Nancy Agmon-Levin, Ferdinand C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, Annette Ladefoged de Thurah, Robert Landewé, Anna Molto, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nico M Wulffraat & Ori Elkayam. (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5:2, pages e001041.
Crossref
Crossref
Lai Shan Tam, James Cheng‐Chung Wei, Amita Aggarwal, Han Joo Baek, Peter P. Cheung, Praveena Chiowchanwisawakit, Leonila Dans, Jieruo Gu, Noboru Hagino, Mitsumasa Kishimoto, Heizel Manapat Reyes, Soosan Soroosh, Simon Stebbings, Samuel Whittle, Swan Sim Yeap & Chak Sing Lau. (2019) 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases 22:3, pages 340-356.
Crossref
Crossref
Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung & Ying-Ming Chiu. (2018) Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Chi Chiu Mok. (2018) Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases. Best Practice & Research Clinical Rheumatology 32:6, pages 767-780.
Crossref
Crossref
Tzu‐Chieh Lin, Kazuki Yoshida, Sara K. Tedeschi, Mirhelen Mendes de Abreu, Nikroo Hashemi & Daniel H. Solomon. (2018) Risk of Hepatitis B Virus Reactivation in Patients With Inflammatory Arthritis Receiving Disease‐Modifying Antirheumatic Drugs: A Systematic Review and Meta‐Analysis. Arthritis Care & Research 70:5, pages 724-731.
Crossref
Crossref
Mohsen Moghoofei, Shayan Mostafaei, Amir Ashraf-Ganjouei, Hoda Kavosi & Mahdi Mahmoudi. (2018) HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis. Microbial Pathogenesis 114, pages 436-443.
Crossref
Crossref
Ying-Ming Chiu, Mei-Shu Lai & K. Arnold Chan. (2017) Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Yi-Ming Chen, Sheng-Shun Yang & Der-Yuan Chen. (2017) Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review. Journal of Microbiology, Immunology and Infection.
Crossref
Crossref
Behnam Azizolahi, Elham Rajaei, Reza Taherkhani & Manoochehr Makvandi. (2017) Low detection of hepatitis B and occult hepatitis B infection in patients with rheumatic diseases. The Egyptian Rheumatologist 39:4, pages 239-243.
Crossref
Crossref
Wanruchada Katchamart, Pongthorn Narongroeknawin, Parawee Chevaisrakul, Pornchai Dechanuwong, Ajanee Mahakkanukrauh, Nuntana Kasitanon, Rattapol Pakchotanon, Kittiwan Sumethkul, Parichat Ueareewongsa, Sittichai Ukritchon, Thitirat Bhurihirun, Kittikorn Duangkum, Porntip Intapiboon, Samanan Intongkam, Wimol Jangsombatsiri, Kanon Jatuworapruk, Naravadee Kositpesat, Pawinee Leungroongroj, Wiyanoot Lomarat, Chonachan Petcharat, Siriluck Sittivutworapant, Patcharawan Suebmee, Pongchirat Tantayakom, Worakan Tipsing, Paijit Asavatanabodee, Praveena Chiowchanwisawakit, Chingching Foocharoen, Ajchara Koolvisoot, Worawit Louthrenoo, Boonjing Siripaitoon, Kitti Totemchokchyakarn & Tasanee Kitumnuaypong. (2017) Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. International Journal of Rheumatic Diseases 20:9, pages 1142-1165.
Crossref
Crossref
Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama, Shinichi Mizuki, Akitomo Okada, Masayuki Miyata, Yuichi Handa, Masatoshi Hayashi, Yoshinobu Koyama, Kaoru Arii, Toshiyuki Kitaori, Hiroyuki Hagiyama, Yoshinori Urushidani, Takahito Yamasaki, Yoshihiko Ikeno, Tsuyoshi Suzuki, Atsushi Omoto, Toshifumi Sugitani, Satoshi Morita & Shigeko Inokuma. (2017) Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan. Annals of the Rheumatic Diseases 76:6, pages 1051-1056.
Crossref
Crossref
Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2017) Hepatitis B Reactivation in Rheumatic Diseases. Rheumatic Disease Clinics of North America 43:1, pages 133-149.
Crossref
Crossref
. (2017) Multiple drugs. Reactions Weekly 1633:1, pages 518-518.
Crossref
Crossref
Satoshi Mochida, Masamitsu Nakao, Nobuaki Nakayama, Yoshihito Uchida, Sumiko Nagoshi, Akio Ido, Toshihide Mimura, Masayoshi Harigai, Hiroshi Kaneko, Hiroko Kobayashi, Tetsuya Tsuchida, Hiromichi Suzuki, Nobuyuki Ura, Yuichi Nakamura, Masami Bessho, Kazuo Dan, Shigeru Kusumoto, Yasutsuna Sasaki, Hirofumi Fujii, Fumitaka Suzuki, Kenji Ikeda, Kazuhiko Yamamoto, Hajime Takikawa, Hirohito Tsubouchi & Masashi Mizokami. (2016) Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies. Journal of Gastroenterology 51:10, pages 999-1010.
Crossref
Crossref
Jun Nakamura, Takao Nagashima, Katsuya Nagatani, Taku Yoshio, Masahiro Iwamoto & Seiji Minota. (2016) Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs. International Journal of Rheumatic Diseases 19:5, pages 470-475.
Crossref
Crossref
Masaru Kato & Tatsuya Atsumi. (2015) Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention. Rheumatology International 36:5, pages 635-641.
Crossref
Crossref
Hannah M. Lee, AnnMarie Liapakis & Joseph K. Lim. (2015) Diagnosis, Management, and Prevention of Hepatitis B Reactivation. Current Hepatology Reports 14:3, pages 184-194.
Crossref
Crossref
Michele Barone, Antonella Notarnicola, Giuseppe Lopalco, Maria Teresa Viggiani, Francesco Sebastiani, Michele Covelli, Florenzo Iannone, Alfonso W. Avolio, Alfredo Di Leo, Luca Cantarini & Giovanni Lapadula. (2015) Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection. Hepatology 62:1, pages 40-46.
Crossref
Crossref
Worawit Louthrenoo. (2015) Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases. Best Practice & Research Clinical Rheumatology 29:2, pages 319-342.
Crossref
Crossref
Ryu Watanabe, Tomonori Ishii & Hideo Harigae. (2015) Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus. The Tohoku Journal of Experimental Medicine 237:1, pages 9-15.
Crossref
Crossref
Robert P. Perrillo, Robert Gish & Yngve T. Falck-Ytter. (2015) American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy. Gastroenterology 148:1, pages 221-244.e3.
Crossref
Crossref
Mar Riveiro-Barciela & María Buti. (2015) Virus de la hepatitis B en el embarazo y el paciente inmunosuprimido. Gastroenterología y Hepatología 38:1, pages 31-39.
Crossref
Crossref
Françoise Lunel-Fabiani, Charles Masson & Alexandra Ducancelle. (2014) Systemic diseases and biotherapies: Understanding, evaluating, and preventing the risk of hepatitis B reactivation. Joint Bone Spine 81:6, pages 478-484.
Crossref
Crossref
Françoise Lunel-Fabiani, Charles Masson & Alexandra Ducancelle. (2014) Maladies systémiques et biomédicaments : comprendre, apprécier et prévenir le risque de réactivation d’hépatite B. Revue du Rhumatisme 81:5, pages 374-380.
Crossref
Crossref
M.I. Biondo, V. Germano, M. Pietrosanti, M. Canzoni, M. Marignani, T. Stroffolini, S. Salemi & R. D'Amelio. (2014) Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies. European Journal of Internal Medicine 25:5, pages 482-484.
Crossref
Crossref
Dandan Xuan, Yiqi Yu, Linyun Shao, Jiali Wang, Wenhong Zhang & Hejian Zou. (2013) Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review. Clinical Rheumatology 33:4, pages 577-586.
Crossref
Crossref
Koichiro Miyagawa, Michihiko Shibata, Shinsuke Kumei, Tooru Matsuhashi, Masaaki Hiura, Shintaro Abe & Masaru Harada. (2014) A case of resolved hepatitis B who was observed HBV viremia transiently during HSV hepatitis immediately after steroid pulse therapy. Kanzo 55:1, pages 51-56.
Crossref
Crossref
Michelle C.M. Cheung & Kosh Agarwal. (2013) Liver abnormalities in the immunosuppressed. Best Practice & Research Clinical Gastroenterology 27:4, pages 597-618.
Crossref
Crossref